Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease.

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

The high-risk procedure, which most hospitals refused due to its difficulty, was executed with precision by a team of specialists, setting a new milestone in advanced cancer treatment. The patient ...

Malignant testicular germ cell tumors are the most common cancers diagnosed in males ages 15 to 39 in the U.S., though ...

The unnamed 52-year-old man did not know he had the disease and he originally visited a doctor complaining of a painless ...

April is Testicular Cancer Awareness Month and at Frontiers in Oncology, we are dedicated to spotlighting the groundbreaking discoveries transforming the ...

A fundraiser is set to be held in Clydebank to raise money for a charity which has helped a Clydebank man through his cancer treatment ...

Researchers have validated a specific cluster of microRNAs (miRNAs) as reliable biomarkers for detecting malignant testicular ...